Gut microbiome–derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease
Nathan D. Mathewson(Broad Institute), Pavan Reddy(Wichita State University), Marco Calafiore(Memorial Sloan Kettering Cancer Center), Yusuke Shono(Memorial Sloan Kettering Cancer Center), Robert R. Jenq(City Of Hope National Medical Center), Jaeman Byun(University of Michigan), Thomas M. Schmidt(University of Michigan), Hideaki Fujiwara(Okayama University Hospital), Katherine Oravecz-Wilson(University of Michigan), Vincent B. Young(University of Michigan), Caroline A. Lindemans(University Medical Center Utrecht), Tomomi Toubai(University of Michigan), Anna V. Mathew(University of Michigan), Mark J. Koenigsknecht(University of Michigan), Subramaniam Pennathur(University of Michigan), Kenya Honda(Keio University), Shin-Rong Wu(University of Michigan), Yaping Sun(Jinan Central Hospital), Alan M. Hanash(Memorial Sloan Kettering Cancer Center), Corinne Rossi(University of Michigan), Marcel R.M. van den Brink(City Of Hope National Medical Center)
Cited by 727
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility
|Cell|2016|2.9k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k